What if the thing changing weight loss, cravings, and even stress levels is a hormone your body already makes?
In this episode of WEvolve, we break down the science behind GLP-1, the hormone that has become the center of conversations around medications like Ozempic, Wegovy, Mounjaro, and Zepbound. We explore how GLP-1 regulates blood sugar, appetite, insulin release, and gastric emptying, while also looking at the growing research connecting these medications to the brain, reward systems, mood, and mental health.
We also talk about the difference between Type 1 and Type 2 diabetes, how GLP-1 receptor agonists work, common side effects, and why “skinny” does not automatically mean healthy. From metabolism and obesity to neuroscience and the gut-brain axis, this episode looks beyond the headlines to understand what these medications are actually doing inside the body.
Topics Covered:
- What GLP-1 is and how it functions
- Ozempic, Wegovy, Mounjaro, and Zepbound
- Blood sugar regulation and insulin
- Appetite, satiety, and weight loss
- The brain-gut connection
- Dopamine, stress, and mental health
- Side effects and misconceptions around GLP-1 drugs
- Why health is more than appearance
#GLP1 #Ozempic #Wegovy #Mounjaro #Zepbound #MentalHealth #Diabetes #WeightLoss #HealthPodcast #WEvolve #GutBrainAxis #PublicHealth #Neuroscience #Wellness
Credits:
Edited by Deetya Datla.
Communications and Management Director - Shivani Senthil-Kumar
Creative and Operations Director - Deeksha Subbagari
Altri episodi di "WEvolve"



Non perdere nemmeno un episodio di “WEvolve”. Iscriviti all'app gratuita GetPodcast.








